Practical approach to the genetic diagnosis of unsolved dystrophinopathies: a stepwise strategy in the genomic era
Authors:
- 25 September 2020
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 58 (11) , 743-751
Abstract
Objective: To investigate the diagnostic value of implementing a stepwise genetic testing strategy (SGTS) in genetically unsolved cases with dystrophinopathies. Methods: After routine genetic testing in 872 male patients with highly suspected dystrophinopathies, we identified 715 patients with a pathogenic DMD variant. Of the 157 patients who had no pathogenic DMD variants and underwent a muscle biopsy, 142 patients were confirmed to have other myopathies, and 15 suspected dystrophinopathies remained genetically undiagnosed. These 15 patients underwent a more comprehensive evaluation as part of the SGTS pipeline, which included the stepwise analysis of dystrophin mRNA, short-read whole-gene DMD sequencing, long-read whole-gene DMD sequencing and in silico bioinformatic analyses. Results: SGTS successfully yielded a molecular diagnosis of dystrophinopathy in 11 of the 15 genetically unsolved cases. We identified 8 intronic and 2 complex structural variants (SVs) leading to aberrant splicing in 10 of 11 patients, of which 9 variants were novel. In one case, a molecular defect was detected on mRNA and protein level only. Aberrant splicing mechanisms included 6 pseudoexon inclusions and 4 alterations of splice sites and splicing regulatory elements. We showed for the first time the exonisation of a MER48 element as a novel pathogenic mechanism in dystrophinopathies. Conclusion: Our study highlights the high diagnostic utility of implementing a SGTS pipeline in dystrophinopathies with intronic variants and complex SVs.Keywords
Funding Information
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z191100006619034)
- Ministry of Science and Technology of the People's Republic of China (2016YFC1300605)
- China Scholarship Council (201906010371)
This publication has 32 references indexed in Scilit:
- Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy PhenotypesPLOS ONE, 2013
- Pure intronic rearrangements leading to aberrant pseudoexon inclusion in dystrophinopathy: a new class of mutations?Human Mutation, 2011
- Antisense Modulation of Both Exonic and Intronic Splicing Motifs Induces Skipping of a DMD Pseudo-Exon Responsible for X-Linked Dilated CardiomyopathyHuman Gene Therapy, 2010
- Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebaseHuman Mutation, 2009
- A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathiesBMC Genomics, 2008
- DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapyAnnals of Neurology, 2007
- A large genomic deletion in thePDHX gene caused by the retrotranspositional insertion of a full-length LINE-1 elementHuman Mutation, 2006
- Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD geneHuman Mutation, 2006
- Pseudoexon activation in theDMD gene as a novel mechanism for Becker muscular dystrophyHuman Mutation, 2003
- A Novel Alu-Like Element Rearranged in the Dystrophin Gene Causes a Splicing Mutation in a Family with X-Linked Dilated CardiomyopathyThe American Journal of Human Genetics, 1998